InflaRx (IFRX) Revenue (2023 - 2025)

InflaRx has disclosed Revenue across 3 years of filings, most recently posting -$85695.7 for Q4 2025.

• Revenue for Q4 2025 came in at -$85695.7, down 18858.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $113738.0 (down 37.34% YoY), and the FY2025 annual result was $34142.6, down 80.73% from the prior year.
• Revenue came in at -$85695.7 for Q4 2025 at InflaRx, down from $116891.5 in the prior quarter.
• In the past five years, Revenue ranged from a high of $135980.4 in Q3 2024 to a low of -$85695.7 in Q4 2025.
• The 3-year median for Revenue is $37906.8 (2025), against an average of $33080.1.
• Peak annual rise in Revenue reached 552.01% in 2025, while the deepest fall reached 18858.56% in 2025.
• InflaRx's Revenue stood at $2459.6 in 2023, then tumbled by 118.38% to -$452.02 in 2024, then sank by 18858.56% to -$85695.7 in 2025.
• The last three Revenue figures came in at -$85695.7 (Q4 2025), $116891.5 (Q3 2025), and $44635.4 (Q2 2025), per Business Quant data.